Progen Phase III Liver Cancer Trial To Initiate In Second Half Of 2007
This article was originally published in The Pink Sheet Daily
Executive Summary
Company announces positive Phase II results studying PI-88 in patients who have undergone surgical removal of liver cancer.
You may also be interested in...
Onyx/Bayer Expect 2008 Launch For Nexavar In Liver Cancer
Companies will submit sNDA as soon as possible following study halt because of “superior overall survival efficacy.”
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.